ArticleFrontiers in immunology2025

Case Report: Therapeutic effect of efgartigimod in refractory anti-GQ1b antibody syndrome coexisting with myasthenia gravis.

Keiko Watanabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.